[Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration]. 1980

A M Zharkovskiĭ, and L K Riago, and A G Arro

Stereotypy elicited by apomorphine, or hyperactivity syndrome (head twitches) induced by 1-tryptophane plus phenelzine was studied in rats during 20 days following chlorpromazine administration for 10 days (10 mg/kg daily). Significant intensification of behavioural effect of apomorphine and especially of 1-tryptophane was observed in neuroleptically pretreated rats. These results point to the development of hypersensitivity of dopamine and serotonin receptors to agonists following chlorpromazine pretreatment. It is suggested that increase in the sensitivity of dopamine and serotonin receptors is of importance for the development of hyperkinetic syndrome during neuroleptic treatment.

UI MeSH Term Description Entries
D008297 Male Males
D010624 Phenelzine One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC. Fenelzin,2-Phenethylhydrazine,Nardelzine,Nardil,Phenelzine Sulfate,Phenethylhydrazine,beta-Phenylethylhydrazine,2 Phenethylhydrazine,Sulfate, Phenelzine,beta Phenylethylhydrazine
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A M Zharkovskiĭ, and L K Riago, and A G Arro
September 1977, British journal of pharmacology,
A M Zharkovskiĭ, and L K Riago, and A G Arro
November 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
A M Zharkovskiĭ, and L K Riago, and A G Arro
January 1985, Journal of neural transmission,
A M Zharkovskiĭ, and L K Riago, and A G Arro
February 1973, Current therapeutic research, clinical and experimental,
A M Zharkovskiĭ, and L K Riago, and A G Arro
July 1974, Arzneimittel-Forschung,
A M Zharkovskiĭ, and L K Riago, and A G Arro
July 1978, Psychopharmacology,
A M Zharkovskiĭ, and L K Riago, and A G Arro
January 1987, Journal of receptor research,
A M Zharkovskiĭ, and L K Riago, and A G Arro
January 1988, Annals of the New York Academy of Sciences,
A M Zharkovskiĭ, and L K Riago, and A G Arro
August 1975, Life sciences,
Copied contents to your clipboard!